Qube Research & Technologies Ltd
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 1729829
LONDON, X0
Position in AGIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,178,346
+$15,829,572 QoQ
Shares Held
597,638
+218.5% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#27
of 238 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. AGIO ranks #26 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in AGIO
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,178,346 | 597,638 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,348,774 | 187,667 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,299,313 | 378,373 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $2,241,025 | 67,379 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,749,814 | 127,980 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,571,014 | 199,970 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,750,647 | 84,417 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,070,669 | 24,830 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,264,454 | 43,244 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,616,992 | 117,512 | Shares | Sole | 2024-02-13 | |
| 2022-12-31 | $1,096,832 | 39,061 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $1,880,038 | 84,801 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,032,415 | 35,466 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,125,501 | 34,241 | Shares | Sole | 2022-02-10 | |
| 2020-09-30 | $608,475 | 17,385 | Shares | Sole | 2020-11-12 | |
| 2020-03-31 | $461,559 | 13,009 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||